Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | IZTC |
---|---|---|
09:32 ET | 3350 | 15 |
09:35 ET | 610 | 14.5409 |
09:42 ET | 1582 | 15.06 |
09:44 ET | 2154 | 15.3909 |
09:46 ET | 3900 | 15.27 |
09:48 ET | 3200 | 15.75 |
09:50 ET | 3421 | 16.25 |
09:51 ET | 5848 | 17.93 |
09:53 ET | 1690 | 18 |
10:00 ET | 3024 | 18.44 |
10:02 ET | 2946 | 18.375 |
10:04 ET | 500 | 18.07 |
10:06 ET | 3139 | 18 |
10:08 ET | 5860 | 17.65 |
10:09 ET | 300 | 17.45 |
10:11 ET | 300 | 17.43 |
10:13 ET | 2538 | 17.375 |
10:15 ET | 369 | 16.767 |
10:24 ET | 220 | 18.24 |
10:26 ET | 420 | 18.24 |
10:27 ET | 200 | 18.079 |
10:31 ET | 250 | 18.16 |
10:40 ET | 100 | 17.7595 |
10:49 ET | 850 | 17.9638 |
10:54 ET | 1434 | 17.49 |
10:56 ET | 400 | 17.2 |
10:58 ET | 100 | 17.47 |
11:02 ET | 100 | 17 |
11:05 ET | 309 | 17 |
11:07 ET | 100 | 16.925 |
11:12 ET | 100 | 17 |
11:18 ET | 300 | 16.53 |
11:30 ET | 257 | 16.6 |
11:34 ET | 500 | 16.75 |
11:36 ET | 200 | 16.5001 |
11:45 ET | 200 | 16.5 |
11:50 ET | 650 | 16.25 |
11:52 ET | 100 | 16.5 |
11:57 ET | 611 | 16.26 |
11:59 ET | 600 | 16 |
12:01 ET | 496 | 16.5 |
12:06 ET | 1100 | 16.135 |
12:10 ET | 1000 | 16.3615 |
12:14 ET | 500 | 16.3998 |
12:17 ET | 749 | 16.5 |
12:19 ET | 2048 | 16.85 |
12:28 ET | 832 | 16.2499 |
12:30 ET | 700 | 15.8862 |
12:33 ET | 1200 | 15.27 |
12:35 ET | 3200 | 15.6132 |
12:37 ET | 3194 | 15.25 |
12:39 ET | 400 | 15.3069 |
12:42 ET | 300 | 15.438 |
12:55 ET | 100 | 15.3 |
01:02 ET | 200 | 15.5 |
01:09 ET | 4110 | 15.3051 |
01:15 ET | 400 | 15.5204 |
01:18 ET | 886 | 15.6677 |
01:22 ET | 804 | 15.755 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Invizyne Technologies Inc | 117.8M | -25.0x | --- |
Outlook Therapeutics Inc | 121.4M | -0.6x | --- |
Ventyx Biosciences Inc | 122.3M | -0.8x | --- |
Vigil Neuroscience Inc | 122.6M | -1.5x | --- |
Context Therapeutics Inc | 112.5M | -1.5x | --- |
Pyxis Oncology Inc | 124.9M | -1.9x | --- |
Invizyne Technologies, Inc. is a biotechnology, pre-revenue, development stage company. The Company's cell-free technology expands its ability to perform enzyme-based conversions, guiding towards sustainable biomanufacturing. The Company is primarily engaged in the development of the SimplePath platform. Its SimplePath platform consists of a series of enzyme based biomanufacturing systems that leverage natural processes to perform complex chemical conversions that convert a starting material into a desired end-product. Each SimplePath system is composed of one or more modules which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. It can provide solutions for natural ingredients (cannabinoids, flavor enhancers for food and beverage products, fragrances, nutraceuticals, organic compounds), pharmaceuticals (natural products with therapeutic properties) and chemicals (commodity chemicals, specialty chemicals, biofuels).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $117.8M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 8.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.63 |
Book Value | $-0.05 |
P/E Ratio | -25.0x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.